Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) vs UnitedHealth Group Inc (UNH) Price & Performance

Roundhill Innov-100 0DTE Covered Call Strat ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Roundhill Innov-100 0DTE Covered Call Strat ETF vs UnitedHealth Group Inc — how do they compare? Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $29.6, while UnitedHealth Group Inc trades at $431 (market cap $396.27B). The key difference: UnitedHealth Group Inc pays a 2.13% dividend while Roundhill Innov-100 0DTE Covered Call Strat ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, Roundhill Innov-100 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.

QDTEUNH
Sector
Income / Options OverlayHealth
52-Week High
$36.60$436.35
52-Week Low
$26.85$237.77
Market Cap
$396.27B
Enterprise Value
$442.96B
Dividend Yield
2.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roundhill Innov-100 0DTE Covered Call Strat ETF

QDTE trades at $29.22, up 0.31% on the day, with technical indicators signaling a bearish trend. The ETF employs a weekly covered call strategy on the Innovation-100 index, generating high distribution yields. Recent news highlights scrutiny over its fee structure and yield sustainability amid declining volatility. Key financial ratios are unavailable in the provided data, limiting fundamental assessment.

The outlook is cautious due to bearish technicals and yield compression risks. Opportunities exist for income-focused investors seeking weekly distributions, but risks include fee drag and volatility dependence. Investor sentiment is mixed, with media questioning yield math while acknowledging competitive returns in certain periods.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $431.31, up 2.32% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations by 29%, and maintains robust cash flow from operations of $19.70 billion in 2025. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.

The outlook remains positive with an 82.69% analyst buy rating and a consensus price target of $476.50, implying 10.5% upside. Key risks include regulatory scrutiny, as seen in Massachusetts' $100 million Medicaid fraud lawsuit filed May 29, 2026, and margin pressure from rising medical costs. Long-term growth is supported by aging demographics and digital health investments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Roundhill Innov-100 0DTE Covered Call Strat ETF

QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.

Read more on QDTE

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH